Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

112 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Timing of Complete Multivessel Revascularization in Patients Presenting With Non-ST-Segment Elevation Acute Coronary Syndrome.
Elscot JJ, Kakar H, Scarparo P, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel RJ, Forlani D, Van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Pinar E, Alfonso F, Cummins P, Lenzen M, Brugaletta S, Daemen J, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. Elscot JJ, et al. Among authors: van mieghem c. JACC Cardiovasc Interv. 2024 Mar 25;17(6):771-782. doi: 10.1016/j.jcin.2024.01.278. JACC Cardiovasc Interv. 2024. PMID: 38538172 Free article. Clinical Trial.
Immediate versus staged complete revascularisation in patients presenting with acute coronary syndrome and multivessel coronary disease (BIOVASC): a prospective, open-label, non-inferiority, randomised trial.
Diletti R, den Dekker WK, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Elscot JJ, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM; BIOVASC Investigators. Diletti R, et al. Among authors: van mieghem c. Lancet. 2023 Apr 8;401(10383):1172-1182. doi: 10.1016/S0140-6736(23)00351-3. Epub 2023 Mar 5. Lancet. 2023. PMID: 36889333 Clinical Trial.
Chronic total occlusion treatment in post-CABG patients: saphenous vein graft versus native vessel recanalization-long-term follow-up in the drug-eluting stent era.
Meliga E, García-García HM, Kukreja N, Daemen J, Tanimoto S, Ramcharitar S, van Mieghem CA, Sianos G, van der Ent M, van der Giessen WJ, de Feyter P, van Domburg R, Serruys PW. Meliga E, et al. Catheter Cardiovasc Interv. 2007 Jul 1;70(1):21-5. doi: 10.1002/ccd.21100. Catheter Cardiovasc Interv. 2007. PMID: 17584913
Three-year clinical outcomes after coronary stenting of chronic total occlusion using sirolimus-eluting stents: insights from the rapamycin-eluting stent evaluated at Rotterdam cardiology hospital-(RESEARCH) registry.
García-García HM, Daemen J, Kukreja N, Tanimoto S, van Mieghem CA, van der Ent M, van Domburg RT, Serruys PW. García-García HM, et al. Catheter Cardiovasc Interv. 2007 Nov 1;70(5):635-9. doi: 10.1002/ccd.21249. Catheter Cardiovasc Interv. 2007. PMID: 17960629
20 years of stenting: a patient's perspective.
Daemen J, van Mieghem C. Daemen J, et al. Among authors: van mieghem c. EuroIntervention. 2006 Nov;2(3):399-401. EuroIntervention. 2006. PMID: 19755320 No abstract available.
112 results